| Due Diligence for Asset Managers |
|---|
|
You have viewed 10 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| UNUM Therapeutics Inc | |
|---|---|
| Ticker | COGT |
| CIK # | 0001622229 |
| CUSIP | 19241Q101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 200 Cambridge Park Drive Suite 3100, Cambridge, MA 02140 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| UNUM Therapeutics Inc | 2020-07-21 | 104.4 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001622229] | 10-K | |
| [0001622229] | 10-Q | |
| [0001622229] | 3 | |
| [0001622229] | 4 | |
| [0001622229] | 8-K | |
| [0001622229] | D | |
| [0001622229] | SC 13D | |
| [0001622229] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fairmount Funds Management LLC
Common Stock
|
2026-03-31 | Sell | 7,000,000 | $34.66 | 242,620,000 |
|
Fairmount Funds Management LLC
Common Stock
|
2026-03-31 | Conversion | 7,000,000 | ||
|
Fairmount Funds Management LLC
Series A Convertible Preferred Stock · derivative
|
2026-03-31 | Conversion | 28,000 | $0.00 | |
|
Fairmount Funds Management LLC
Common Stock
|
2026-01-22 | Sell | 3,500,000 | $36.40 | 127,400,000 |
|
Ferrante Karen Jean
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 643 | $0.00 | |
|
Green John L
Common Stock
|
2025-12-26 | Sell | 77,000 | $38.68 | 2,978,360 |
|
Robinson John Edward
Common Stock
|
2025-12-26 | Sell | 90,000 | $38.74 | 3,486,600 |
|
Kearns Evan
Common Stock
|
2025-12-26 | Sell | 65,000 | $38.70 | 2,515,500 |
|
Sachs Jessica
Common Stock
|
2025-12-26 | Sell | 82,642 | $38.70 | 3,198,245 |
|
Pinnow Cole
Common Stock
|
2025-12-17 | Grant | 50,000 | $0.00 | |
|
Sachs Jessica
Common Stock
|
2025-12-17 | Grant | 320,000 | $0.00 | |
|
Sachs Jessica
Common Stock
|
2025-12-17 | Grant | 50,000 | $0.00 | |
|
Kearns Evan
Common Stock
|
2025-12-17 | Grant | 40,000 | $0.00 | |
|
Kearns Evan
Common Stock
|
2025-12-17 | Grant | 260,000 | $0.00 | |
|
Kearns Evan
Common Stock
|
2025-12-17 | Tax withheld | 125,602 | $39.45 | 4,954,999 |
|
Green John L
Common Stock
|
2025-12-17 | Tax withheld | 145,007 | $39.45 | 5,720,526 |
|
Green John L
Common Stock
|
2025-12-17 | Grant | 50,000 | $0.00 | |
|
Green John L
Common Stock
|
2025-12-17 | Grant | 300,000 | $0.00 | |
|
Robinson John Edward
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Grant | 65,000 | $0.00 | |
|
Robbins Andrew R
Stock Option (Right to Buy) · derivative
|
2025-12-17 | Grant | 245,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 308 | 181,445,833 |
| 2025-12-31 | 269 | 170,631,045 |
| 2025-09-30 | 195 | 160,373,351 |
| 2025-06-30 | 181 | 138,406,310 |
| 2025-03-31 | 187 | 132,304,710 |
| 2024-12-31 | 178 | 120,882,962 |
| 2024-09-30 | 162 | 121,799,885 |
| 2024-06-30 | 149 | 122,324,638 |
| 2024-03-31 | 148 | 112,965,012 |
| 2023-12-31 | 146 | 93,590,219 |
| 2023-09-30 | 136 | 90,815,042 |
| 2023-06-30 | 137 | 88,449,844 |